01 March 1999
Molecular and therapeutical aspects of the blood platelet receptors antagonistsMarcin Różalski, Magdalena Boncler, Bogusława Więcławska, Cezary Watała
Med Sci Monit 1999; 5(2): RA357-375 :: ID: 505175
Many new, potent, antiplatelet agents belonging to the group of platelet receptors antagonists became recently available for clinical evaluation and intervention. Amongst platelet inhibitors of a newer generation including inhibitors of platelet adhesion, inhibitors of specific platelet agonist-receptor interactions (antithrombins, fibrinogen receptor antagonists, thromboxane A2, receptor antagonists, ADP receptor blockers like ticlopidine and clopidogrel, or inhibitors of thromboxane synthase and arachidonic acid metabolism), only the antagonists of platelet receptors have been demonstrated to allow more global interruption of both the initial and final steps of platelet-dependent prothrombotic events. Due to the considerable progress in the development of novel agents aimed to reducing platelet-derived thrombosis, various antiplatelet drugs have been invented, which are rationally based on interrupting specific sites in the sequence of platelet activation, adhesion and aggregation. The antagonists of platelet receptors focus considerable attention, because they are able to directly interfere with the interactions between blood platelets and their ligands. The common feature of these agents is that they are designed to interrupt platelet response at the very initial stage of platelet activation - when the 'outside-in receptor-mediated' triggers signal transduction in platelet cytoplasm. In that sense, the antagonists of platelet receptors are believed to represent quite a new approach to the treatment of platelet thrombosis.
Keywords: antiplatelet drugs, peptidomimetics, monoclonal antibodies, RGD-derived ligands, peptidomimetics
01 March 2023 : EditorialEditorial: Global Surveillance of Highly Pathogenic Avian Influenza Viruses in Poultry, Wild Birds, and Mammals to Prevent a Human Influenza Pandemic
Med Sci Monit 2023; 29:e939968
09 February 2023 : Clinical ResearchEvaluation of Health-Related Quality of Life and Mental Health in 729 Medical Students in Indonesia During ...
Med Sci Monit 2023; 29:e938892
19 January 2023 : Clinical ResearchDetermining the Impact of the COVID-19 Pandemic on Dental Care in the Serbian Adult Population: An Online Q...
Med Sci Monit 2023; 29:e939238
27 December 2022 : Clinical ResearchEffect of Physiotherapy to Correct Rounded Shoulder Posture in 30 Patients During the COVID-19 Pandemic in ...
Med Sci Monit 2022; 28:e938926
10 December 2022 : Clinical ResearchRetrospective Study to Identify Risk Factors for Severe Disease and Mortality Using the Modified Early Warn...
Med Sci Monit 2022; 28:e938647
27 Mar 2023 : Database AnalysisRelationship Between Physical Activity and Adult Asthma Control Using NHANES 2011-2020 Data
Med Sci Monit In Press; DOI: 10.12659/MSM.939350
27 Mar 2023 : Clinical ResearchEvaluation of the One-Hour ¹³C-Propionate Breath Test in 49 Patients from a Single Center in Japan to Detec...
Med Sci Monit In Press; DOI: 10.12659/MSM.940238
24 Mar 2023 : Database AnalysisCauses of Death Following Gastric Cancer Diagnosis: A Population-Based Analysis
Med Sci Monit In Press; DOI: 10.12659/MSM.939848
22 Mar 2023 : Special reportOne Year On: Poland’s Public Health Initiatives and National Response to Millions of Refugees from Ukraine
Med Sci Monit In Press; DOI: 10.12659/MSM.940223
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : EditorialEditorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...
Med Sci Monit 2022; 28:e935952